Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-15 Sale | 2024-11-20 08:23 am | Skye Bioscience Inc. | SKYE | Diep Tuan Tu Chief Development Officer | 19,574 | $4.9924 | $97,722 | 82,259 (Direct) | View |
| 2024-11-15 Sale | 2024-11-19 9:57 pm | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 43,396 | $4.9925 | $216,652 | 166,342 (Direct) | View |
| 2024-11-15 Sale | 2024-11-19 9:20 pm | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 82,910 | $4.9925 | $413,925 | 339,166 (Indirect Direct) | View |
| 2024-11-15 Sale | 2024-11-19 9:14 pm | Skye Bioscience Inc. | SKYE | Grayson Paul A. Director | 86,551 | $4.992 | $432,061 | 259,701 (Direct) | View |
| 2024-09-11 Sale | 2024-09-13 6:56 pm | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 266,337 | $6.5719 | $1,750,352 | 66,277 (Indirect) | View |
| 2024-09-11 Sale | 2024-09-13 6:54 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 266,337 | $6.5719 | $1,750,352 | 66,277 (Indirect) | View |
| 2024-03-13 Purchase | 2024-03-15 4:15 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 450,000 | $10 | $4,500,000 | 10,179,505 (Indirect) | View |
| 2024-01-31 Purchase | 2024-02-02 4:32 pm | Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner | 5,206,074 | $2.31 | $12,026,031 | 9,729,505 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-28 Option Award | 2024-10-30 8:33 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | Diep Tuan Tu Chief Development Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-30 8:32 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-30 8:31 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 650,000 | $0 | 650,000 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-30 8:30 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 70,000 | $0 | 70,000 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-30 8:29 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | Grayson Paul A. Director | 70,000 | $0 | 70,000 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-30 8:28 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | Smith Karen L. Director | 70,000 | $0 | 70,000 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-30 8:25 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | Charych Deborah H. Director | 70,000 | $0 | 70,000 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-30 8:25 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | Jenkins Annalisa Director | 70,000 | $0 | 70,000 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-04 6:12 pm | N/A 2034-09-03 | Skye Bioscience Inc. | SKYE | Arora Puneet S. Chief Medical Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2024-08-26 Other | 2024-08-27 5:20 pm | N/A N/A | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 15,727 | $0 | 437,803 (Direct) | View |
| 2024-07-02 Option Award | 2024-07-05 08:59 am | N/A 2034-07-01 | Skye Bioscience Inc. | SKYE | Smith Karen L. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 4:15 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 450,000 | $10 | 10,179,505 (Indirect) | View |
| 2024-02-29 Option Award | 2024-03-04 7:53 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Grayson Paul A. Director | 135,000 | $0 | 381,252 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 6:02 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Charych Deborah H. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 6:01 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Jenkins Annalisa Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 4:04 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 06:24 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | DALESANDRO MARGARET Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 06:23 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Ward Keith Wayne Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 06:20 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 06:19 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Diep Tuan Tu Chief Development Officer | 100,000 | $0 | 176,833 (Direct) | View |
| 2024-02-29 Option Award(A) | 2024-03-04 06:15 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 100,000 | $0 | 284,738 (Direct) | View |
| 2024-02-29 Option Award(A) | 2024-03-04 06:13 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 225,000 | $0 | 522,006 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-01 6:42 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 100,000 | $0 | 285,738 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-01 6:24 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 225,000 | $0 | 522,006 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:35 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 5,206,074 | $2.31 | 9,729,505 (Indirect) | View |
| 2023-11-06 Option Award | 2023-11-06 8:32 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Ward Keith Wayne Director | 14,110 | $0 | 20,001 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-06 8:30 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Charych Deborah H. Director | 14,110 | $0 | 20,001 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer | 160,262 | $0 | 231,174 (Direct) | View |